NCT04380415View on ClinicalTrials.gov

Validation of Software for Assessment of Atrial Fibrillation From PPG Data Acquired by a Wearable Smartwatch

NACompletedINTERVENTIONAL

Enrollment

450,000

Participants

Timeline

Start Date

May 6, 2020

Primary Completion Date

March 8, 2021

Study Completion Date

March 8, 2021

Conditions

Atrial Fibrillation

Interventions

DIAGNOSTIC_TEST

Single lead ambulatory ECG patch

Single lead ambulatory ECG patch worn on the chest

Trial Locations (2)

94107

PlushCare, San Francisco

02114

Massachusetts General Hospital, Boston

All Listed Sponsors

lead

Fitbit LLC

INDUSTRY

NCT04380415 - Validation of Software for Assessment of Atrial Fibrillation From PPG Data Acquired by a Wearable Smartwatch | Biotech Hunter | Biotech Hunter